NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Earli

Earli

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.earli.com/

Last Round

Series B

Apr 23, 2026

Total Funding Raised

$128M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Earli is a biotechnology company that develops cancer-programmable genetic constructs that activate exclusively in cancer cells to produce synthetic biomarkers for early detection and personalized treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

synthetic biopsyearly cancer detectioncancer diagnosticsin vivo imagingliquid biopsybiomarker detectiontumor localizationprecision oncologycancer screeningbiotech startupearly detection technext-gen diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Earli Comps

Public and private peers based on sector, stage, and business model.

Earli comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Earli Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BApr 23, 2026
VC RoundAug 15, 2025
SeedOct 15, 2024
StrategicAug 19, 2024
Series AJan 12, 2021
Seed
Sep 1, 2018

Key People

Founding team and executive leadership

David Suhy

Chief Scientific Officer And Co-Founder

Founding Team

Cyriac Roeding

Co-founder, CEO

Founding Team

Earli Investors

Notable investors and investment history

Earli investors
InvestorRounds
Andreessen HorowitzStrategic, Series A, VC Round, Seed
Breyer CapitalSeries A
Perceptive AdvisorsSeries A, Strategic, VC Round
Han River PartnersStrategic, VC Round
Khosla VenturesStrategic, VC Round, Series A
ZhenFundSeed
Zeev VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Technology based on original research from Stanford University's Gambhir lab.

  • Aug 15, 2025

    $44M raised with participation from Andreessen Horowitz and Khosla Ventures.

Earli Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Earli Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Earli's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range36
Year Founded2018
Last FundingApr 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.